Chamomile for Chronic Primary Insomnia
Completed · Phase 2 · Has a placebo group
Conditions studied: Primary Insomnia, Chronic Insomnia
In brief
The purpose of this study is to determine if an herb called chamomile can help to treat insomnia (difficulty in going to sleep or getting enough sleep) by increasing the amount of time that you sleep and/or improving the quality of your sleep. The study will also be looking at the effect of chamomile on day time fatigue and functioning.
Key facts
- Study ID
- NCT01286324
- Run by
- University of Michigan
- People needed
- 34
- Starts
- 2008-07-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2017-11-07
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women aged 18 to 64 years;
- Must be able to give written informed consent;
- Have a diagnosis of primary insomnia per DSM-IV criteria, reporting < 6.5 hours sleep and/or >30 minutes to fall asleep (SOL) and/or wake after sleep onset (WASO) > 30 minutes, three or more nights per week;
- Present sleep complaint for at least 6 months;
You may not qualify if…
- Women who are pregnant, lactating or less than six months post-partum. Due to the fact that an assessment of reproductive performance and teratology tests have not been conducted we are excluding pregnant and lactating women;
- Patients with unstable medical conditions;
- DSM-IV Axis I or personality disorder diagnosis with the exception of patients with treated and stable unipolar depression or generalized anxiety disorder (such that the PRIME-MD scores are within normal range for these disorders);
- Difficulty in sleep initiation or maintenance associated with known medical diagnosis or conditions that may affect sleep, e.g., sleep apnea, restless leg syndrome, chronic pain;
- Evidence of lack of reliability or noncompliance as defined by missing a pretreatment appointment more than twice;
- Current diagnosis of substance abuse or dependence;
- Known allergy to chamomile or members of the ragweed family;
- Currently taking cyclosporine, warfarin or chronic sedative and anxiolytic medications;
- Prior use of insomnia medications is not exclusionary, but patients must be off of these medications at the screening visit and through out the study.
Where it is running
- University of Michigan Department of Family Medicine — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.